Oakview Capital Management’s Merck MRK Stock Holding History

Oakview Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-202	Closed	-$12K	–	18
2017 Q1	$12K	Hold	202	–	–	0.01%	37
2016 Q4	$11K	Buy	+202	New	+$11.8K	0.01%	36

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Oakview Capital Management's MRK Position: Q2 2017 in Review

Oakview Capital Management sold out of Merck (MRK) in Q2 2017, closing a stake of 202 shares — an estimated $12K sold.

Oakview Capital Management first reported a position in MRK in Q4 2016 and held it in 2 quarters. The position peaked at $12K in Q1 2017. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

Oakview Capital Management reported no remaining Merck position as of Q2 2017 after selling out during the quarter.
Oakview Capital Management sold 202 Merck shares in Q2 2017, an estimated $12K.
Oakview Capital Management first reported a position in Merck in Q4 2016 and held it in 2 quarters.
Oakview Capital Management's Merck position peaked at $12K in Q1 2017.
1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Oakview Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.